Global Intranasal Drug and Vaccine Delivery Devices Supply, Demand and Key Producers, 2023-2029
The global Intranasal Drug and Vaccine Delivery Devices market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Delivery devices for intranasal drugs and vaccines
This report studies the global Intranasal Drug and Vaccine Delivery Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intranasal Drug and Vaccine Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intranasal Drug and Vaccine Delivery Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intranasal Drug and Vaccine Delivery Devices total production and demand, 2018-2029, (K Units)
Global Intranasal Drug and Vaccine Delivery Devices total production value, 2018-2029, (USD Million)
Global Intranasal Drug and Vaccine Delivery Devices production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Intranasal Drug and Vaccine Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Intranasal Drug and Vaccine Delivery Devices production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect, Aptar Pharma, 3M, OptiNose, UCB and Bespak, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intranasal Drug and Vaccine Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intranasal Drug and Vaccine Delivery Devices Market, By Region:
1. How big is the global Intranasal Drug and Vaccine Delivery Devices market?
2. What is the demand of the global Intranasal Drug and Vaccine Delivery Devices market?
3. What is the year over year growth of the global Intranasal Drug and Vaccine Delivery Devices market?
4. What is the production and production value of the global Intranasal Drug and Vaccine Delivery Devices market?
5. Who are the key producers in the global Intranasal Drug and Vaccine Delivery Devices market?
6. What are the growth factors driving the market demand?
Delivery devices for intranasal drugs and vaccines
This report studies the global Intranasal Drug and Vaccine Delivery Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intranasal Drug and Vaccine Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intranasal Drug and Vaccine Delivery Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intranasal Drug and Vaccine Delivery Devices total production and demand, 2018-2029, (K Units)
Global Intranasal Drug and Vaccine Delivery Devices total production value, 2018-2029, (USD Million)
Global Intranasal Drug and Vaccine Delivery Devices production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Intranasal Drug and Vaccine Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Intranasal Drug and Vaccine Delivery Devices production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intranasal Drug and Vaccine Delivery Devices production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect, Aptar Pharma, 3M, OptiNose, UCB and Bespak, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intranasal Drug and Vaccine Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intranasal Drug and Vaccine Delivery Devices Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Powder Conveyor
- Liquid Delivery Device
- Pressurized Metered Dose Inhaler
- Other
- Respiratory Diseases
- Nervous System Disease
- Vaccination
- Pain Department
- Other
- Teva Pharmaceuticals
- GlaxoSmithKline
- Teleflex
- Intersect
- Aptar Pharma
- 3M
- OptiNose
- UCB
- Bespak
1. How big is the global Intranasal Drug and Vaccine Delivery Devices market?
2. What is the demand of the global Intranasal Drug and Vaccine Delivery Devices market?
3. What is the year over year growth of the global Intranasal Drug and Vaccine Delivery Devices market?
4. What is the production and production value of the global Intranasal Drug and Vaccine Delivery Devices market?
5. Who are the key producers in the global Intranasal Drug and Vaccine Delivery Devices market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intranasal Drug and Vaccine Delivery Devices Introduction
1.2 World Intranasal Drug and Vaccine Delivery Devices Supply & Forecast
1.2.1 World Intranasal Drug and Vaccine Delivery Devices Production Value (2018 & 2022 & 2029)
1.2.2 World Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.2.3 World Intranasal Drug and Vaccine Delivery Devices Pricing Trends (2018-2029)
1.3 World Intranasal Drug and Vaccine Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018-2029)
1.3.2 World Intranasal Drug and Vaccine Delivery Devices Production by Region (2018-2029)
1.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2029)
1.3.4 North America Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.5 Europe Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.6 China Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.7 Japan Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intranasal Drug and Vaccine Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intranasal Drug and Vaccine Delivery Devices Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intranasal Drug and Vaccine Delivery Devices Demand (2018-2029)
2.2 World Intranasal Drug and Vaccine Delivery Devices Consumption by Region
2.2.1 World Intranasal Drug and Vaccine Delivery Devices Consumption by Region (2018-2023)
2.2.2 World Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Region (2024-2029)
2.3 United States Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.4 China Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.5 Europe Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.6 Japan Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.7 South Korea Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.8 ASEAN Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.9 India Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
3 WORLD INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intranasal Drug and Vaccine Delivery Devices Production Value by Manufacturer (2018-2023)
3.2 World Intranasal Drug and Vaccine Delivery Devices Production by Manufacturer (2018-2023)
3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Intranasal Drug and Vaccine Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intranasal Drug and Vaccine Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intranasal Drug and Vaccine Delivery Devices in 2022
3.5.3 Global Concentration Ratios (CR8) for Intranasal Drug and Vaccine Delivery Devices in 2022
3.6 Intranasal Drug and Vaccine Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Intranasal Drug and Vaccine Delivery Devices Market: Region Footprint
3.6.2 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
3.6.3 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Comparison
4.1.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Comparison
4.2.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Comparison
4.3.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.4.3 United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
4.5 China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share
4.5.1 China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.5.3 China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
4.6 Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intranasal Drug and Vaccine Delivery Devices Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder Conveyor
5.2.2 Liquid Delivery Device
5.2.3 Pressurized Metered Dose Inhaler
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Intranasal Drug and Vaccine Delivery Devices Production by Type (2018-2029)
5.3.2 World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2018-2029)
5.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intranasal Drug and Vaccine Delivery Devices Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Respiratory Diseases
6.2.2 Nervous System Disease
6.2.3 Vaccination
6.2.4 Pain Department
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Intranasal Drug and Vaccine Delivery Devices Production by Application (2018-2029)
6.3.2 World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2018-2029)
6.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Details
7.1.2 Teva Pharmaceuticals Major Business
7.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
7.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceuticals Recent Developments/Updates
7.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Details
7.2.2 GlaxoSmithKline Major Business
7.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
7.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 Teleflex
7.3.1 Teleflex Details
7.3.2 Teleflex Major Business
7.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
7.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teleflex Recent Developments/Updates
7.3.6 Teleflex Competitive Strengths & Weaknesses
7.4 Intersect
7.4.1 Intersect Details
7.4.2 Intersect Major Business
7.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
7.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Intersect Recent Developments/Updates
7.4.6 Intersect Competitive Strengths & Weaknesses
7.5 Aptar Pharma
7.5.1 Aptar Pharma Details
7.5.2 Aptar Pharma Major Business
7.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
7.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Aptar Pharma Recent Developments/Updates
7.5.6 Aptar Pharma Competitive Strengths & Weaknesses
7.6 3M
7.6.1 3M Details
7.6.2 3M Major Business
7.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
7.6.4 3M Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 3M Recent Developments/Updates
7.6.6 3M Competitive Strengths & Weaknesses
7.7 OptiNose
7.7.1 OptiNose Details
7.7.2 OptiNose Major Business
7.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
7.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 OptiNose Recent Developments/Updates
7.7.6 OptiNose Competitive Strengths & Weaknesses
7.8 UCB
7.8.1 UCB Details
7.8.2 UCB Major Business
7.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
7.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UCB Recent Developments/Updates
7.8.6 UCB Competitive Strengths & Weaknesses
7.9 Bespak
7.9.1 Bespak Details
7.9.2 Bespak Major Business
7.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
7.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Bespak Recent Developments/Updates
7.9.6 Bespak Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain
8.2 Intranasal Drug and Vaccine Delivery Devices Upstream Analysis
8.2.1 Intranasal Drug and Vaccine Delivery Devices Core Raw Materials
8.2.2 Main Manufacturers of Intranasal Drug and Vaccine Delivery Devices Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intranasal Drug and Vaccine Delivery Devices Production Mode
8.6 Intranasal Drug and Vaccine Delivery Devices Procurement Model
8.7 Intranasal Drug and Vaccine Delivery Devices Industry Sales Model and Sales Channels
8.7.1 Intranasal Drug and Vaccine Delivery Devices Sales Model
8.7.2 Intranasal Drug and Vaccine Delivery Devices Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Intranasal Drug and Vaccine Delivery Devices Introduction
1.2 World Intranasal Drug and Vaccine Delivery Devices Supply & Forecast
1.2.1 World Intranasal Drug and Vaccine Delivery Devices Production Value (2018 & 2022 & 2029)
1.2.2 World Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.2.3 World Intranasal Drug and Vaccine Delivery Devices Pricing Trends (2018-2029)
1.3 World Intranasal Drug and Vaccine Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018-2029)
1.3.2 World Intranasal Drug and Vaccine Delivery Devices Production by Region (2018-2029)
1.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2029)
1.3.4 North America Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.5 Europe Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.6 China Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.3.7 Japan Intranasal Drug and Vaccine Delivery Devices Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intranasal Drug and Vaccine Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intranasal Drug and Vaccine Delivery Devices Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intranasal Drug and Vaccine Delivery Devices Demand (2018-2029)
2.2 World Intranasal Drug and Vaccine Delivery Devices Consumption by Region
2.2.1 World Intranasal Drug and Vaccine Delivery Devices Consumption by Region (2018-2023)
2.2.2 World Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Region (2024-2029)
2.3 United States Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.4 China Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.5 Europe Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.6 Japan Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.7 South Korea Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.8 ASEAN Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
2.9 India Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029)
3 WORLD INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intranasal Drug and Vaccine Delivery Devices Production Value by Manufacturer (2018-2023)
3.2 World Intranasal Drug and Vaccine Delivery Devices Production by Manufacturer (2018-2023)
3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Intranasal Drug and Vaccine Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intranasal Drug and Vaccine Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intranasal Drug and Vaccine Delivery Devices in 2022
3.5.3 Global Concentration Ratios (CR8) for Intranasal Drug and Vaccine Delivery Devices in 2022
3.6 Intranasal Drug and Vaccine Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Intranasal Drug and Vaccine Delivery Devices Market: Region Footprint
3.6.2 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
3.6.3 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Comparison
4.1.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Comparison
4.2.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Comparison
4.3.1 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.4.3 United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
4.5 China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share
4.5.1 China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.5.3 China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
4.6 Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intranasal Drug and Vaccine Delivery Devices Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder Conveyor
5.2.2 Liquid Delivery Device
5.2.3 Pressurized Metered Dose Inhaler
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Intranasal Drug and Vaccine Delivery Devices Production by Type (2018-2029)
5.3.2 World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2018-2029)
5.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intranasal Drug and Vaccine Delivery Devices Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Respiratory Diseases
6.2.2 Nervous System Disease
6.2.3 Vaccination
6.2.4 Pain Department
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Intranasal Drug and Vaccine Delivery Devices Production by Application (2018-2029)
6.3.2 World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2018-2029)
6.3.3 World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Details
7.1.2 Teva Pharmaceuticals Major Business
7.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
7.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceuticals Recent Developments/Updates
7.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Details
7.2.2 GlaxoSmithKline Major Business
7.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
7.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 Teleflex
7.3.1 Teleflex Details
7.3.2 Teleflex Major Business
7.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
7.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teleflex Recent Developments/Updates
7.3.6 Teleflex Competitive Strengths & Weaknesses
7.4 Intersect
7.4.1 Intersect Details
7.4.2 Intersect Major Business
7.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
7.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Intersect Recent Developments/Updates
7.4.6 Intersect Competitive Strengths & Weaknesses
7.5 Aptar Pharma
7.5.1 Aptar Pharma Details
7.5.2 Aptar Pharma Major Business
7.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
7.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Aptar Pharma Recent Developments/Updates
7.5.6 Aptar Pharma Competitive Strengths & Weaknesses
7.6 3M
7.6.1 3M Details
7.6.2 3M Major Business
7.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
7.6.4 3M Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 3M Recent Developments/Updates
7.6.6 3M Competitive Strengths & Weaknesses
7.7 OptiNose
7.7.1 OptiNose Details
7.7.2 OptiNose Major Business
7.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
7.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 OptiNose Recent Developments/Updates
7.7.6 OptiNose Competitive Strengths & Weaknesses
7.8 UCB
7.8.1 UCB Details
7.8.2 UCB Major Business
7.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
7.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UCB Recent Developments/Updates
7.8.6 UCB Competitive Strengths & Weaknesses
7.9 Bespak
7.9.1 Bespak Details
7.9.2 Bespak Major Business
7.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
7.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Bespak Recent Developments/Updates
7.9.6 Bespak Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain
8.2 Intranasal Drug and Vaccine Delivery Devices Upstream Analysis
8.2.1 Intranasal Drug and Vaccine Delivery Devices Core Raw Materials
8.2.2 Main Manufacturers of Intranasal Drug and Vaccine Delivery Devices Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intranasal Drug and Vaccine Delivery Devices Production Mode
8.6 Intranasal Drug and Vaccine Delivery Devices Procurement Model
8.7 Intranasal Drug and Vaccine Delivery Devices Industry Sales Model and Sales Channels
8.7.1 Intranasal Drug and Vaccine Delivery Devices Sales Model
8.7.2 Intranasal Drug and Vaccine Delivery Devices Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018-2023) & (USD Million)
Table 3. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2024-2029) & (USD Million)
Table 4. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2018-2023)
Table 5. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2024-2029)
Table 6. World Intranasal Drug and Vaccine Delivery Devices Production by Region (2018-2023) & (K Units)
Table 7. World Intranasal Drug and Vaccine Delivery Devices Production by Region (2024-2029) & (K Units)
Table 8. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2018-2023)
Table 9. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2024-2029)
Table 10. World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Intranasal Drug and Vaccine Delivery Devices Major Market Trends
Table 13. World Intranasal Drug and Vaccine Delivery Devices Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Intranasal Drug and Vaccine Delivery Devices Consumption by Region (2018-2023) & (K Units)
Table 15. World Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Intranasal Drug and Vaccine Delivery Devices Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Intranasal Drug and Vaccine Delivery Devices Producers in 2022
Table 18. World Intranasal Drug and Vaccine Delivery Devices Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Intranasal Drug and Vaccine Delivery Devices Producers in 2022
Table 20. World Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Intranasal Drug and Vaccine Delivery Devices Company Evaluation Quadrant
Table 22. World Intranasal Drug and Vaccine Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Intranasal Drug and Vaccine Delivery Devices Production Site of Key Manufacturer
Table 24. Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
Table 25. Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
Table 26. Intranasal Drug and Vaccine Delivery Devices Competitive Factors
Table 27. Intranasal Drug and Vaccine Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Intranasal Drug and Vaccine Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Intranasal Drug and Vaccine Delivery Devices Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Intranasal Drug and Vaccine Delivery Devices Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Intranasal Drug and Vaccine Delivery Devices Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 37. China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 42. Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 47. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Intranasal Drug and Vaccine Delivery Devices Production by Type (2018-2023) & (K Units)
Table 49. World Intranasal Drug and Vaccine Delivery Devices Production by Type (2024-2029) & (K Units)
Table 50. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2018-2023) & (USD Million)
Table 51. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2024-2029) & (USD Million)
Table 52. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Intranasal Drug and Vaccine Delivery Devices Production by Application (2018-2023) & (K Units)
Table 56. World Intranasal Drug and Vaccine Delivery Devices Production by Application (2024-2029) & (K Units)
Table 57. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2018-2023) & (USD Million)
Table 58. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2024-2029) & (USD Million)
Table 59. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceuticals Major Business
Table 63. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 64. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceuticals Recent Developments/Updates
Table 66. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Major Business
Table 69. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 70. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GlaxoSmithKline Recent Developments/Updates
Table 72. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 73. Teleflex Basic Information, Manufacturing Base and Competitors
Table 74. Teleflex Major Business
Table 75. Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 76. Teleflex Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teleflex Recent Developments/Updates
Table 78. Teleflex Competitive Strengths & Weaknesses
Table 79. Intersect Basic Information, Manufacturing Base and Competitors
Table 80. Intersect Major Business
Table 81. Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 82. Intersect Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Intersect Recent Developments/Updates
Table 84. Intersect Competitive Strengths & Weaknesses
Table 85. Aptar Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Aptar Pharma Major Business
Table 87. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 88. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Aptar Pharma Recent Developments/Updates
Table 90. Aptar Pharma Competitive Strengths & Weaknesses
Table 91. 3M Basic Information, Manufacturing Base and Competitors
Table 92. 3M Major Business
Table 93. 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 94. 3M Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 3M Recent Developments/Updates
Table 96. 3M Competitive Strengths & Weaknesses
Table 97. OptiNose Basic Information, Manufacturing Base and Competitors
Table 98. OptiNose Major Business
Table 99. OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 100. OptiNose Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. OptiNose Recent Developments/Updates
Table 102. OptiNose Competitive Strengths & Weaknesses
Table 103. UCB Basic Information, Manufacturing Base and Competitors
Table 104. UCB Major Business
Table 105. UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 106. UCB Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UCB Recent Developments/Updates
Table 108. Bespak Basic Information, Manufacturing Base and Competitors
Table 109. Bespak Major Business
Table 110. Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 111. Bespak Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Intranasal Drug and Vaccine Delivery Devices Upstream (Raw Materials)
Table 113. Intranasal Drug and Vaccine Delivery Devices Typical Customers
Table 114. Intranasal Drug and Vaccine Delivery Devices Typical Distributors
Table 1. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2018-2023) & (USD Million)
Table 3. World Intranasal Drug and Vaccine Delivery Devices Production Value by Region (2024-2029) & (USD Million)
Table 4. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2018-2023)
Table 5. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2024-2029)
Table 6. World Intranasal Drug and Vaccine Delivery Devices Production by Region (2018-2023) & (K Units)
Table 7. World Intranasal Drug and Vaccine Delivery Devices Production by Region (2024-2029) & (K Units)
Table 8. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2018-2023)
Table 9. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2024-2029)
Table 10. World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Intranasal Drug and Vaccine Delivery Devices Major Market Trends
Table 13. World Intranasal Drug and Vaccine Delivery Devices Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Intranasal Drug and Vaccine Delivery Devices Consumption by Region (2018-2023) & (K Units)
Table 15. World Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Intranasal Drug and Vaccine Delivery Devices Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Intranasal Drug and Vaccine Delivery Devices Producers in 2022
Table 18. World Intranasal Drug and Vaccine Delivery Devices Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Intranasal Drug and Vaccine Delivery Devices Producers in 2022
Table 20. World Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Intranasal Drug and Vaccine Delivery Devices Company Evaluation Quadrant
Table 22. World Intranasal Drug and Vaccine Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Intranasal Drug and Vaccine Delivery Devices Production Site of Key Manufacturer
Table 24. Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
Table 25. Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
Table 26. Intranasal Drug and Vaccine Delivery Devices Competitive Factors
Table 27. Intranasal Drug and Vaccine Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Intranasal Drug and Vaccine Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Intranasal Drug and Vaccine Delivery Devices Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Intranasal Drug and Vaccine Delivery Devices Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Intranasal Drug and Vaccine Delivery Devices Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 37. China Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 42. Rest of World Based Intranasal Drug and Vaccine Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share (2018-2023)
Table 47. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Intranasal Drug and Vaccine Delivery Devices Production by Type (2018-2023) & (K Units)
Table 49. World Intranasal Drug and Vaccine Delivery Devices Production by Type (2024-2029) & (K Units)
Table 50. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2018-2023) & (USD Million)
Table 51. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type (2024-2029) & (USD Million)
Table 52. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Intranasal Drug and Vaccine Delivery Devices Production by Application (2018-2023) & (K Units)
Table 56. World Intranasal Drug and Vaccine Delivery Devices Production by Application (2024-2029) & (K Units)
Table 57. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2018-2023) & (USD Million)
Table 58. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application (2024-2029) & (USD Million)
Table 59. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceuticals Major Business
Table 63. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 64. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceuticals Recent Developments/Updates
Table 66. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Major Business
Table 69. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 70. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GlaxoSmithKline Recent Developments/Updates
Table 72. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 73. Teleflex Basic Information, Manufacturing Base and Competitors
Table 74. Teleflex Major Business
Table 75. Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 76. Teleflex Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teleflex Recent Developments/Updates
Table 78. Teleflex Competitive Strengths & Weaknesses
Table 79. Intersect Basic Information, Manufacturing Base and Competitors
Table 80. Intersect Major Business
Table 81. Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 82. Intersect Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Intersect Recent Developments/Updates
Table 84. Intersect Competitive Strengths & Weaknesses
Table 85. Aptar Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Aptar Pharma Major Business
Table 87. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 88. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Aptar Pharma Recent Developments/Updates
Table 90. Aptar Pharma Competitive Strengths & Weaknesses
Table 91. 3M Basic Information, Manufacturing Base and Competitors
Table 92. 3M Major Business
Table 93. 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 94. 3M Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 3M Recent Developments/Updates
Table 96. 3M Competitive Strengths & Weaknesses
Table 97. OptiNose Basic Information, Manufacturing Base and Competitors
Table 98. OptiNose Major Business
Table 99. OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 100. OptiNose Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. OptiNose Recent Developments/Updates
Table 102. OptiNose Competitive Strengths & Weaknesses
Table 103. UCB Basic Information, Manufacturing Base and Competitors
Table 104. UCB Major Business
Table 105. UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 106. UCB Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UCB Recent Developments/Updates
Table 108. Bespak Basic Information, Manufacturing Base and Competitors
Table 109. Bespak Major Business
Table 110. Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
Table 111. Bespak Intranasal Drug and Vaccine Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Intranasal Drug and Vaccine Delivery Devices Upstream (Raw Materials)
Table 113. Intranasal Drug and Vaccine Delivery Devices Typical Customers
Table 114. Intranasal Drug and Vaccine Delivery Devices Typical Distributors
LIST OF FIGURES
Figure 1. Intranasal Drug and Vaccine Delivery Devices Picture
Figure 2. World Intranasal Drug and Vaccine Delivery Devices Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intranasal Drug and Vaccine Delivery Devices Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 5. World Intranasal Drug and Vaccine Delivery Devices Average Price (2018-2029) & (US$/Unit)
Figure 6. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2018-2029)
Figure 7. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2018-2029)
Figure 8. North America Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 9. Europe Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 10. China Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 11. Japan Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 12. Intranasal Drug and Vaccine Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 15. World Intranasal Drug and Vaccine Delivery Devices Consumption Market Share by Region (2018-2029)
Figure 16. United States Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 17. China Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 18. Europe Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 19. Japan Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 20. South Korea Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 22. India Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Intranasal Drug and Vaccine Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intranasal Drug and Vaccine Delivery Devices Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intranasal Drug and Vaccine Delivery Devices Markets in 2022
Figure 26. United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 30. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 32. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Type in 2022
Figure 34. Powder Conveyor
Figure 35. Liquid Delivery Device
Figure 36. Pressurized Metered Dose Inhaler
Figure 37. Other
Figure 38. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Type (2018-2029)
Figure 39. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Type (2018-2029)
Figure 40. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Application in 2022
Figure 43. Respiratory Diseases
Figure 44. Nervous System Disease
Figure 45. Vaccination
Figure 46. Pain Department
Figure 47. Other
Figure 48. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Application (2018-2029)
Figure 49. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Application (2018-2029)
Figure 50. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Intranasal Drug and Vaccine Delivery Devices Industry Chain
Figure 52. Intranasal Drug and Vaccine Delivery Devices Procurement Model
Figure 53. Intranasal Drug and Vaccine Delivery Devices Sales Model
Figure 54. Intranasal Drug and Vaccine Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Intranasal Drug and Vaccine Delivery Devices Picture
Figure 2. World Intranasal Drug and Vaccine Delivery Devices Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intranasal Drug and Vaccine Delivery Devices Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 5. World Intranasal Drug and Vaccine Delivery Devices Average Price (2018-2029) & (US$/Unit)
Figure 6. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Region (2018-2029)
Figure 7. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Region (2018-2029)
Figure 8. North America Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 9. Europe Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 10. China Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 11. Japan Intranasal Drug and Vaccine Delivery Devices Production (2018-2029) & (K Units)
Figure 12. Intranasal Drug and Vaccine Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 15. World Intranasal Drug and Vaccine Delivery Devices Consumption Market Share by Region (2018-2029)
Figure 16. United States Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 17. China Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 18. Europe Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 19. Japan Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 20. South Korea Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 22. India Intranasal Drug and Vaccine Delivery Devices Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Intranasal Drug and Vaccine Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intranasal Drug and Vaccine Delivery Devices Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intranasal Drug and Vaccine Delivery Devices Markets in 2022
Figure 26. United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Intranasal Drug and Vaccine Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intranasal Drug and Vaccine Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 30. China Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Intranasal Drug and Vaccine Delivery Devices Production Market Share 2022
Figure 32. World Intranasal Drug and Vaccine Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Type in 2022
Figure 34. Powder Conveyor
Figure 35. Liquid Delivery Device
Figure 36. Pressurized Metered Dose Inhaler
Figure 37. Other
Figure 38. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Type (2018-2029)
Figure 39. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Type (2018-2029)
Figure 40. World Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Intranasal Drug and Vaccine Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Application in 2022
Figure 43. Respiratory Diseases
Figure 44. Nervous System Disease
Figure 45. Vaccination
Figure 46. Pain Department
Figure 47. Other
Figure 48. World Intranasal Drug and Vaccine Delivery Devices Production Market Share by Application (2018-2029)
Figure 49. World Intranasal Drug and Vaccine Delivery Devices Production Value Market Share by Application (2018-2029)
Figure 50. World Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Intranasal Drug and Vaccine Delivery Devices Industry Chain
Figure 52. Intranasal Drug and Vaccine Delivery Devices Procurement Model
Figure 53. Intranasal Drug and Vaccine Delivery Devices Sales Model
Figure 54. Intranasal Drug and Vaccine Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
